September 14, 2010

HELIX BIOPHARMA APPROVED FOR NYSE AMEX LISTING (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: “HXBPF”) today announced that it has been authorized to list its shares of common stock on the NYSE Amex stock exchange. The Company expects that shares of its common stock will begin trading on the NYSE Amex on September 15, 2010, under the trading symbol “HBP.” The Company will delist from the OTCQX once trading begins on the NYSE Amex. The Company’s listings on the Toronto and Frankfurt Stock Exchanges are unaffected by today’s announcement.